Skip navigation
Por favor, use este identificador para citar o enlazar este ítem: http://repositorio.unb.br/handle/10482/29740
Ficheros en este ítem:
Fichero Tamaño Formato  
ARTIGO_TreatmentPsoriasisPsoriaticArthritis.pdf174,67 kBAdobe PDFVisualizar/Abrir
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorKurizky, Patricia Shupt_BR
dc.contributor.authorFerreira, Clarissa de Castropt_BR
dc.contributor.authorNogueira, Lucas Souza Carmopt_BR
dc.contributor.authorMota, Licia Maria Henrique dapt_BR
dc.date.accessioned2017-12-07T05:13:05Z-
dc.date.available2017-12-07T05:13:05Z-
dc.date.issued2015-05pt_BR
dc.identifier.citationKURIZKY, Patricia Shu et al. Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding. Anais Brasileiros de Dermatologia, Rio de Janeiro, v. 90, n. 3, p. 367-375, maio/jun. 2015. Disponível em: <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962015000300367&lng=en&nrm=iso>. Acesso em: 11 abr. 2018. doi: http://dx.doi.org/10.1590/abd1806-4841.20153113.pt_BR
dc.identifier.urihttp://repositorio.unb.br/handle/10482/29740-
dc.language.isoenpt_BR
dc.publisherSociedade Brasileira de Dermatologiapt_BR
dc.rightsAcesso Abertopt_BR
dc.titleTreatment of psoriasis and psoriatic arthritis during pregnancy and breastfeedingpt_BR
dc.typeArtigopt_BR
dc.subject.keywordArtritept_BR
dc.subject.keywordLactaçãopt_BR
dc.subject.keywordGravidezpt_BR
dc.subject.keywordPsoríasept_BR
dc.rights.licenseAnais Brasileiros de Dermatologia - This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY NC 3.0). Fonte: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962015000300367&lng=en&nrm=iso. Acesso em: 11 abr. 2018.-
dc.identifier.doihttp://dx.doi.org/10.1590/abd1806-4841.20153113pt_BR
dc.description.abstract1Psoriasis is a chronic inflammatory disease that affects primarily the skin and joints, with a worldwide incidence of 2-3%. Fifty percent of patients are women, most still diagnosed during childbearing years. Currently,the estimate is that up to 107 thousand deliveries are performed annually in women with psoriasis, a percentage of them in women with moderate to severe disease. Fetal risks in pregnant women with psoriasis derive both from maternal disease and the medications used to control the illness. The purpose of this review is to study the effect of the main drugs used in the treatment of psoriasis and psoriatic arthritis during pregnancy and lactation, with particular focus on disease-modifying anti-rheumatic biological drugs, biological therapies, immunobiologics or biologics.-
dc.description.unidadeFaculdade de Medicina (FM)-
Aparece en las colecciones: Artigos publicados em periódicos e afins

Mostrar el registro sencillo del ítem " class="statisticsLink btn btn-primary" href="/handle/10482/29740/statistics">



Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.